We are live on ! Find out more
WEC

Winslow Evans & Crocker Portfolio holdings

AUM $528M
1-Year Est. Return 30.99%
This Fund
S&P 500
This Quarter Est. Return
+24.39%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.2%
5 Year Est. Return
+147.26%
10 Year Est. Return
AUM
$375M
AUM Growth
+$70.9M
Cap. Flow
+$6.82M
Cap. Flow %
1.82%
Top 10 Hldgs %
27.07%
Holding
1,203
New
83
Increased
198
Reduced
494
Closed
49

Sector Composition

Rank Sector Weight
1 Technology 27.09%
2 Healthcare 15.02%
3 Financials 10.96%
4 Consumer Discretionary 9.84%
5 Communication Services 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPMB icon
851
JPMorgan USD Emerging Markets Sovereign Bond ETF
JPMB
$67.2M
$6K ﹤0.01%
125
-1
-0.8% -$46
MRCY icon
852
Mercury Systems
MRCY
$5.83B
$6K ﹤0.01%
75
-1
-1% -$82
POWI icon
853
Power Integrations
POWI
$3.38B
$6K ﹤0.01%
106
-2
-2% -$105
PRU icon
854
Prudential Financial
PRU
$42.4B
$6K ﹤0.01%
105
-87
-45% -$5.11K
QDF icon
855
FlexShares Quality Dividend Index Fund
QDF
$2.22B
$6K ﹤0.01%
150
REFR icon
856
Research Frontiers
REFR
$14M
$6K ﹤0.01%
1,495
-1
-0.1% -$4
RQI icon
857
Cohen & Steers Quality Income Realty Fund
RQI
$1.7B
$6K ﹤0.01%
586
SDGR icon
858
Schrodinger
SDGR
$1.13B
$6K ﹤0.01%
61
-1
-2% -$58
TXT icon
859
Textron
TXT
$14.7B
$6K ﹤0.01%
168
VFH icon
860
Vanguard Financials ETF
VFH
$13.5B
$6K ﹤0.01%
100
VMI icon
861
Valmont Industries
VMI
$9.3B
$6K ﹤0.01%
+50
New +$5.55K
XITK icon
862
State Street SPDR FactSet Innovative Technology ETF
XITK
$70M
$6K ﹤0.01%
40
SMC
863
Summit Midstream
SMC
$426M
$6K ﹤0.01%
407
ITCI
864
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6K ﹤0.01%
240
SRNE
865
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$6K ﹤0.01%
+1,000
New +$3.83K
CLVS
866
DELISTED
Clovis Oncology, Inc.
CLVS
$6K ﹤0.01%
880
SWCH
867
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$6K ﹤0.01%
351
+111
+46% +$1.94K
MXIM
868
DELISTED
Maxim Integrated Products
MXIM
$6K ﹤0.01%
95
-1
-1% -$56
FVL
869
DELISTED
First TrustValue Line 100 Exchange-Traded
FVL
$6K ﹤0.01%
300
ALLY icon
870
Ally Financial
ALLY
$13.2B
$5K ﹤0.01%
+250
New +$4.25K
ATO icon
871
Atmos Energy
ATO
$28.8B
$5K ﹤0.01%
54
BILL icon
872
BILL Holdings
BILL
$4.49B
$5K ﹤0.01%
50
BL icon
873
BlackLine
BL
$1.84B
$5K ﹤0.01%
+61
New +$4.07K
CGEN icon
874
Compugen
CGEN
$222M
$5K ﹤0.01%
325
-1
-0.3% -$13
CNNE icon
875
Cannae Holdings
CNNE
$639M
$5K ﹤0.01%
114

Similar funds

Winslow Evans & Crocker's Q2 2020 Portfolio in Review

As of Q2 2020, Winslow Evans & Crocker held 1,203 positions worth $375M, up 23% from $304M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Winslow Evans & Crocker's Q2 2020 filing shows 83 new, 198 increased, 494 reduced and 49 closed positions. Its largest new stake was Vertex Pharmaceuticals: 2,423 shares worth $703K. The largest sale was HDFC Bank, an estimated $692K.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Winslow Evans & Crocker's largest Q2 2020 buy was Vertex Pharmaceuticals: 2,423 shares worth $703K.
  • Winslow Evans & Crocker added most to RingCentral in Q2 2020, an estimated $764K increase.
  • Winslow Evans & Crocker's biggest Q2 2020 reduction was HDFC Bank, cutting an estimated $692K.
  • Winslow Evans & Crocker fully exited Kansas City Southern in Q2 2020, selling an estimated $388K.
  • Winslow Evans & Crocker's ten largest holdings make up 27% of its $375M portfolio in Q2 2020.
  • Winslow Evans & Crocker opened 83 new positions and closed 49 in Q2 2020.
  • Winslow Evans & Crocker's portfolio value rose 23% quarter-over-quarter to $375M.

Based on Winslow Evans & Crocker's 13F filing for Q2 2020, filed 23 Jul 2020.